[HTML][HTML] Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis

C Stein, H Nassereldine, RJD Sorensen, JO Amlag… - The Lancet, 2023 - thelancet.com
Background Understanding the level and characteristics of protection from past SARS-CoV-
2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe …

Risk factors of severe COVID-19: a review of host, viral and environmental factors

L Zsichla, V Müller - Viruses, 2023 - mdpi.com
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar

H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle… - Nature …, 2022 - nature.com
Abstract SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants are genetically divergent. We
conducted a matched, test-negative, case-control study to estimate duration of protection of …

Effects of previous infection and vaccination on symptomatic omicron infections

HN Altarawneh, H Chemaitelly, HH Ayoub… - … England Journal of …, 2022 - Mass Medical Soc
Background The protection conferred by natural immunity, vaccination, and both against
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with …

Estimated protection of prior SARS-CoV-2 infection against reinfection with the Omicron variant among messenger RNA–vaccinated and nonvaccinated individuals in …

S Carazo, DM Skowronski, M Brisson… - JAMA network …, 2022 - jamanetwork.com
Importance The Omicron variant is phylogenetically and antigenically distinct from earlier
SARS-CoV-2 variants and the original vaccine strain. Protection conferred by prior SARS …

Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B. 1.1. 529): a prospective cohort study from Shenzhen, China

Y Yang, L Guo, J Yuan, Z Xu, Y Gu, J Zhang… - The Lancet …, 2023 - thelancet.com
Background Elucidating viral dynamics within the host is important for designing public
health measures against SARS-CoV-2, particularly during the early stages of infection when …

Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population

ML Lind, M Dorion, AJ Houde, M Lansing… - Nature …, 2023 - nature.com
Whether SARS-CoV-2 infection and COVID-19 vaccines confer exposure-dependent
(“leaky”) protection against infection remains unknown. We examined the effect of prior …

Impact of National Omicron Outbreak at the end of 2022 on the future outlook of COVID-19 in China

L Zheng, S Liu, F Lu - Emerging Microbes & Infections, 2023 - Taylor & Francis
The sudden change of public health policy in containing COVID-19 in China around 7
December 2022 and the subsequent immediate large-scale outbreak of severe acute …

COVID-19 infection, reinfection, and the transition to endemicity

C Cohen, J Pulliam - The Lancet, 2023 - thelancet.com
Understanding the protection conferred by previous infection against repeat infection,
illness, and severe disease is key to projecting the future epidemiology of COVID-19 and to …

Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA. 1 and BA. 2 Omicron infections and severe COVID-19 in Qatar

HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang… - MedRxiv, 2022 - medrxiv.org
BACKGROUND Protection offered by five different forms of immunity, combining natural and
vaccine immunity, was investigated against SARS-CoV-2 Omicron symptomatic BA. 1 …